See Allo

Nisha Virginia, author

Kualitas hidup dan tingkat kepatuhan penggunaan imatinib mesilat pada pasien Leukemia Granulositik Kronik di RS Kanker Dharmais Jakarta = Quality of life and adherence to imatinib mesylate therapy inchronic myeloid Leukemia Patients at Dharmais Cancer Hospital Jakarta

Fakultas Farmasi Universitas Indonesia, 2020

UI - Tesis Membership

Hilman Tadjoedin, author

Peran Mutasi Gen BCR-Abl pada Perjalanan Klinis Pasien Leukemia Granulositik Kronik (LGK): Kaitannya dengan Aspek Terapi Imatinib Mesylate (IM) = The Role of BCR-Abl Gene Mutation in Clinical Course of Chronic Myeloid Leukemia Patients (CML): Relation to Aspects of Imatinib Mesylate Therapy (IM)

Fakultas Kedokteran Universitas Indonesia, 2015

UI - Disertasi Membership

M. Chandra Haikal, author

Penemuan inhibitor BCR-ABL terbarukan menggunakan penapisan virtual berbasis farmakofor dan simulasi dinamika molekul dalam terapi obat leukemia = Discovery of a novel BCR-ABL inhibitor using pharmacophore based virtual screening and molecular dynamics simulation in leukemia drug therapy

2018

UI - Skripsi Membership

Reni Widyastuti, author

Hubungan Mutasi T315I Gen ABL1 dengan Pencapaian Major Molecular Response (MMR) pada Pasien Leukemia Granulositik Kronik Fase Kronik yang Mendapat Imatinib = Association between T315I Mutation in ABL1 Gene to the Achievement of Major Molecular Response (MMR) in Chronic Phase of Chronic Myeloid Leukemia Patients Treated with Imatinib

Fakultas Kedokteran Universitas Indonesia, 2019

UI - Tesis Membership

Anastasia Putri, author

Hubungan ekspresi gen stat5a dan stat5b dengan pencapaian major molecular response (MMR) pada pasien leukemia granulositik kronik yang mendapat imatinib = Expression of stat5a and stat5b and its relation to achievement of major molecular response in patient with chronic phase chronic myeloid leukemia on imatinib treatment

Fakultas Kedokteran Universitas Indonesia, 2019

UI - Tesis Membership

<< 1 2 3 >>